Get Flat 20% Discount on All Medications
  • Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter
    You are here: Home > Pharmacy News | Health Articles/Tips > Sun Pharma > March 14, 2012

      Sun Pharma Advanced Research Company Announces Rights Issue to Conduct Clinical Trial of Paclitaxel in US

      Sun Pharma Advanced Research Company (SPARC), an India-based publicly listed pharma research company, has announced that it will issue additional shares to fund its clinical trials to be conducted in the US. SPARC plans to raise gross proceeds of up to $44.6 million from this rights issue to its existing shareholders. The company will utilize the raised funds to conduct the first phase of tests to study the safety and efficacy of Paclitaxel, a new form of cancer injection, in the US. Also, it intends to use a significant amount of the funds to repay its debts.

      Paclitaxel is a cancer chemotherapy drug that is licensed to treat advanced stage of cancer of the ovary, breast and lung. SPARC aims to develop and test a new patient-friendly administration protocol for Paclitaxel, namely a Paclitaxel Injection Concentrate for Nano dispersion (PICN) that is safer, with a short infusion time and high-dose drug delivery to tumor tissues.


      Share this Article!

    Back to top^